Epstein-Barr virus association in classical Hodgkin's disease provides survival advantage to patients and correlates with higher expression of proliferation markers in Reed-Sternberg cells

Annals of Oncology

Volumn 11, Issue 1, 2000, Pages 91-96

  Naresh, K N ^a   Johnson, J ^b   Srinivas, V ^a   Soman, C S ^a   Saikia, T ^a   Advani, S H ^a   Badwe, R A ^a   Dinshaw, K A ^a   Muckaden, M ^a   Magrath, I ^b   Bhatia, K ^b  

^a TATA MEMORIAL HOSPITAL   (India)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Epstein Barr virus; Hodgkin's disease; Proliferation; Reed Sternberg cell

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CANCER SURVIVAL; CELL PROLIFERATION; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; FEMALE; HODGKIN DISEASE; HUMAN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; REED STERNBERG CELL; SCHOOL CHILD; VIRUS INFECTION;

ADOLESCENT; ADULT; ANTIGENS, VIRAL; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; HERPESVIRUS 4, HUMAN; HODGKIN DISEASE; HUMANS; LYMPH NODES; MALE; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROLIFERATING CELL NUCLEAR ANTIGEN; REED-STERNBERG CELLS; RETROSPECTIVE STUDIES; RNA, MESSENGER; RNA, VIRAL; SURVIVAL ANALYSIS; TIME FACTORS; VIRAL MATRIX PROTEINS;

EID: 0033953119     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008337100424     Document Type: Article

References (36)

1. Nilsson K, Klein G, Henle W, Henle G. The establishment of lymphoblastoid lines from adult and fetal human lymphoid tissue and its dependence on EBV. Int J Cancer 1971; 8: 443-50.
2. Anagnostopoulos I. Hummel M. Epstein Barr virus in tumours. Histopathology 1996; 29: 297-315.
3. Rajewsky K, Kanzler H, Hansmann ML, Kuppers R. Normal and malignant B-cell development with special reference to Hodgkin's disease. Ann Oncol 1997; 8 (Suppl 2): 79-81.
4. Korkolopoulou P, Cordell J, Jones M et al. The expression of the B-cell marker mb-1 (CD79a) in Hodgkin's disease. Histopathology 1994; 24: 511-5.
5. Glaser SL, Lin RJ, Stewart SL et al. A Epstein Barr virus-associated Hodgkin's disease: Epidemiologic characteristics in international data. Int J Cancer 1997; 70: 375 82.
6. Jarrett AF, Armstrong AA, Alexander E. Epidemiology of EBV and Hodgkin's lymphoma. Ann Oncol 1996; 7 (Suppl 4): 5-10.
7. Schmid C, Sweeney E, Isaacson PG. Proliferating cell nuclear antigen (PCNA) expression in Hodgkin's disease. J Pathol 1992; 168: 1-6.
8. Claviez A, Tiemann M, Peters J et al. The impact of EBV, proliferation rate, and BCL-2 expression in Hodgkin s disease in childhood. Ann Hematol 1994: 68: 61-6.
9. Zhou XG, Hamilton-Dutoit SJ, Yan QH, Pallesen G. The association between Epstein Barr virus and Chinese Hodgkin's disease. Int J Cancer 1993; 55: 359-63.
10. Huh J, Park C, Juhng S et al. A pathologic study of Hodgkin's disease in Korea and its association with Epstein Barr virus infection. Cancer 1996; 77: 949-55.
11. Li D, Oda K, Mikata A, Yumoto N. Epstein Barr virus genomes in Hodgkin's disease and non-Hodgkin's lymphomas. Pathol Int 1995; 45: 735-41.
12. Lauritzen AF, Hording U, Nielsen HW. Epstein Barr virus and Hodgkin's disease: A comparative immunological, in situ hybridization, and polymerase chain reaction study. APMIS 1994; 102: 495-500.
13. Herbst H, Steinbrecher E, Niedobitek G et al. Distribution and phenotype of Epstein Barr virus-harboring cells in Hodgkin's disease. Blood 1992; 80: 484-91.
14. Ohshima K, Haraoka S, Fujiki T et al. Expressions of cyclin E, A, and B1 in Hodgkin and Reed Sternberg cells: Not suppressed by cyclin-dependent kinase inhibitor p21 expression. Pathol Int 1999; 49: 506-12.
15. Czader M, Porwit A, Ost A, Auer G. DNA content and expression of PCNA and p53 in Hodgkin's disease and Hodgkin's-like B-cell lymphoma. APMIS 1994; 102: 865-873.
16. Sabattini H, Gerdes J, Gherlinzoni F et al. Comparison between the monoclonal antibodies Ki-67 and PC10 in 125 malignant lymphomas. J Pathol 1993; 169: 397-403.
17. Gupta RK, Lister TA, Bodmer JG. Proliferation of Reed Sternberg cells and variants in Hodgkin's disease. Ann Oncol 1994; 5 (Suppl 1): 117-9.
18. Leoncini L, Megha T, Lazzi S et al. Cellular kinetic differences between Hodgkin's and anaplastic large-cell lymphomas: Relation to the expression of p34cdc2 and cyclin B-1. Int J Cancer 1998; 77: 408-4.
19. Harris NL, Jaffe ES, Stein H et al. A Revised European American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361-92.
20. Harris NL. The many faces of Hodgkin's disease around the world: What have we learned from its pathology? Ann Oncol 1998; 9 (Suppl 5): S45-56.
21. Zarate-Osorno A. Roman LN, Kingma DW et al. Hodgkin's disease in Mexico. Prevalence of Epstein Barr virus sequences and correlations with histologic subtype. Cancer 1995; 75: 1360-6.
22. Monterroso V, Zhou Y, Koo Set al. Hodgkin's disease in Costa Rica: A report of 40 cases analyzed for Epstein Barr virus. Am J Clin Pathol 1998; 109: 618-624.
23. Leoncini L, Spina D, Nyong'o A et al. Neoplastic cells of Hodgkin's disease show differences in EBV expression between Kenya and Italy. Int J Cancer 1996; 65: 781-4.
24. Weinreb M, Day PJ, Niggli F et al. The role of Epstein Barr virus in Hodgkin's disease from different geographical areas. Arch Dis Child 1996; 74: 27-31.
25. Tomita Y, Ohsawa M, Kanno H et al. Epstein Barr virus in Hodgkin's disease patients in Japan. Cancer 1996; 77: 186-92.
26. Chan JK, Yip TT, Tsang WY et al. Detection of Epstein Barr virus in Hodgkin's disease occurring in an Oriental population. Hum Pathol 1995; 26: 314-8.
27. Belkaid MI, Briere J, Djebbara Z et al. Comparison of Epstein Barr virus markers in Reed Sternberg cells in adult Hodgkin's disease tissues from an industrialized and a developing country. Leuk Lymph 1995; 17: 163-8.
28. Gulley ML, Eagan PA, Quintanilla-Martinez L et al. Epstein Barr virus DNA is abundant and monoclonal in the Reed Sternberg cells of Hodgkin's disease: Association with mixed cellularity subtype and Hispanic American ethnicity. Blood 1994; 83: 1595-602.
29. Razzouk BI, Gan YJ, Mendonca C et al. Epstein Barr virus in pediatric Hodgkin disease: Age and histiotype are more predictive than geographic region. Med Pediatr Oncol 1997; 28: 248-54.
30. Armstrong AA, Alexander FE. Paes RP et al. Association of Epstein Barr virus with pediatric Hodgkin's disease. Am J Pathol 1993; 142: 1683-8.
31. Teramoto N, Cao L, Kawasaki N et al. Variable expression of Epstein Barr virus latent membrane protein I in Reed Sternberg cells of Hodgkin's disease. Acta Med Okayama 1996 50: 267-70.
32. Morente MM, Piris MA, Abraira V et al. Adverse clinical outcome in Hodgkin's disease is associated with loss of retinoblastoma protein expression, high Ki67 proliferation index, and absence of Epstein Barr virus-latent membrane protein 1 expression. Blood 1997; 90: 2429-36.
33. Murray PG, Billingham LJ, Hassan HT et al. Effect of Epstein Barr virus infection on response to chemotherapy and survival in Hodgkin's disease. Blood 1999; 94: 442-7.
34. Fellbaum C, Hansmann ML, Niedermeyer H et al. Influence of Epstein Barr virus genomes on patient survival in Hodgkin's disease. Am J Clin Pathol 1992; 98: 319-23.
35. Nguyen D. Nathwani BN, Ellison DJ, Hackett C. Differential diagnosis between T-cell lymphoma and Hodgkin's disease: The value of mitotic counts and pericapsular infiltration. Hematol Pathol 1989; 3: 63-71.
36. Drexler HG, Gignac SM, Hoffbrand AV, Minowada J. Formation of multinucleated cells in a Hodgkin's-disease-derived cell line. Int J Cancer 1989; 43: 1083-90.